KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,002 | -25.1% | 32,838 | 0.0% | 0.00% | – |
| Q2 2023 | $58,780 | -69.1% | 32,838 | -32.8% | 0.00% | – |
| Q1 2023 | $190,073 | -1.6% | 48,862 | -14.0% | 0.00% | – |
| Q4 2022 | $193,137 | +77.2% | 56,805 | +186.5% | 0.00% | – |
| Q3 2022 | $109,000 | +19.8% | 19,827 | -2.3% | 0.00% | – |
| Q2 2022 | $91,000 | -6.2% | 20,299 | +54.9% | 0.00% | – |
| Q1 2022 | $97,000 | +24.4% | 13,104 | +7.7% | 0.00% | – |
| Q4 2021 | $78,000 | -55.7% | 12,172 | -59.9% | 0.00% | – |
| Q3 2021 | $176,000 | -40.7% | 30,365 | +5.6% | 0.00% | – |
| Q2 2021 | $297,000 | -11.6% | 28,742 | -10.0% | 0.00% | – |
| Q1 2021 | $336,000 | -34.8% | 31,953 | -4.0% | 0.00% | – |
| Q4 2020 | $515,000 | +49.7% | 33,272 | +41.6% | 0.00% | – |
| Q3 2020 | $344,000 | -27.7% | 23,500 | -6.5% | 0.00% | – |
| Q2 2020 | $476,000 | -75.9% | 25,129 | -60.7% | 0.00% | -100.0% |
| Q1 2014 | $1,977,000 | -22.3% | 64,000 | -42.3% | 0.00% | -20.0% |
| Q4 2013 | $2,544,000 | – | 111,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |